Pfizer ends COVID-19 trial with 95% efficacy, to seek emergency-use authorization ...Egypt

Pfizer Inc said on Wednesday that final results from the late-stage trial of its COVID-19 vaccine show it was 95% effective, adding it had the required two-months of safety data and would apply for emergency U.S. authorization within days. The drugmaker said efficacy of the vaccine developed with (...)

Read More Details
Finally We wish PressBee provided you with enough information of ( Pfizer ends COVID-19 trial with 95% efficacy, to seek emergency-use authorization )

Also on site :

• The Beths Announce North American Tour Dates Alongside New Single, ‘Metal’
• Four dead after car crashes into after-school camp in US state of Illinois
• Child Damages $56 Million Rothko Painting in Rotterdam Museum